| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 64263-99-6 | N-[N-[N-[N-[(1,1-Dimethylethoxy)carbonyl]-L-alanyl]glycyl]glycyl]-Glycine | C14H24N4O7 |
| 64264-44-4 | Heptadecafluoro-N-[2-(Phosphonooxy)Ethyl]-N-Propyloctanesulphonamide | C13H13F17NO6PS |
| 64265-10-7 | 4-Nitro-1H-benzimidazol-5-ol | C7H5N3O3 |
| 64265-11-8 | 4-Nitro-1H-benzimidazol-6-ol | C7H5N3O3 |
| 64265-12-9 | 5-Nitro-1H-benzimidazol-7-ol | C7H5N3O3 |
| 64265-45-8 | N-(2-Hydroxyethyl)-N-[2-[(1-Oxooctyl)Amino]Ethyl]-beta-Alanine | C15H30N2O4 |
| 64265-49-2 | N-[2-[Bis(2-Hydroxyethyl)Amino]Ethyl]Stearamide Monohydrochloride | C24H51ClN2O3 |
| 64265-57-2 | Trimethylolpropane tris(2-methyl-1-aziridinepropionate) | C24H41N3O6 |
| 64265-77-6 | (R)-1-(4-Bromophenyl)ethylamine hydrochloride | C8H10BrN.HCl |
| 64265-94-7 | 9-Oxo-10,12,15-Octadecatrienoic Acid | C18H28O3 |
| 64266-18-8 | 3-(2-Methyl-1H-benzimidazol-1-yl)propanenitrile | C11H11N3 |
| 64266-25-7 | 3-(2-Ethyl-1H-benzimidazol-1-yl)propanenitrile | C12H13N3 |
| 64266-26-8 | 3-(2-Amino-1H-benzimidazol-1-yl)propanenitrile | C10H10N4 |
| 64267-12-5 | 3-Benzoyl-7-methoxycoumarin | C17H12O4 |
| 64267-17-0 | 3,3'-Carbonylbis(7-Methoxycoumarin) | C21H14O7 |
| 64267-46-5 | Disnogamycin | C37H47NO14 |
| 64267-47-6 | (2R)-4alpha-(Dimethylamino)-3,4,5,6,11,12,13,14-Octahydro-3beta,5beta,8,10,13alpha-Pentahydroxy-11beta-Methoxy-6,13-Dimethyl-2alpha,6alpha-Epoxy-2H-Naphthaceno[1,2-b]Oxocin-9,16-Dione | C28H31NO10 |
| 64267-73-8 | D-Galactose-d | C6H11DO6 |
| 64267-98-7 | Met(2)-Pro(5)-Enkephalin | C30H39N5O7S |
| 64268-81-1 | Ethyl 4-amino-1-piperazinecarboxylate | C7H15N3O2 |
| 64268-93-5 | 1-[(4-Nitrophenyl)Sulfonyl]-Piperidine | C11H14N2O4S |
| 64269-03-0 | [[1-(Morpholino)cyclohexan-1-yl]methyl]amine | C11H22N2O |
| 64269-06-3 | 1-Anilinocyclohexanecarbonitrile | C13H16N2 |
| 64269-81-4 | Bis(2-Imidazolyl)methane | C7H8N4 |
| 64270-99-1 | 1-(5-Methyl-2-Furyl)Ethanamine | C7H12NO |
| 64271-00-7 | 1-(5-Methylfuran-2-yl)propylamine | C8H13NO |
| 64271-33-6 | O-4,6-O-Cyclohexylidene-3-deoxy-3-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-D-glucopyranosyl-(1→6)-O-[2,3,4,6-tetradeoxy-2,6-bis[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-D-erythro-hex-3-enopyranosyl-(1→4)]-2-deoxy-N1,N3-bis[(1,1-dimethylethoxy)carbonyl]-D-streptamine | C49H83N5O18 |
| 64272-26-0 | CGP13156 | C25H31ClF2O5 |
| 64272-68-0 | (1S)-1,4-Anhydro-1-(1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-D-ribitol | C11H16N2O6 |
| 64273-10-5 | Di-N-(2-nitro-4-azidophenyl)cystamine-S,S-dioxide | C16H16N10O6S2 |
| 64273-28-5 | 5-Methyl-4-Phenyl-1,2,3-Thiadiazole | C9H8N2S |
| 64274-28-8 | Aucubigenin | C9H12O4 |
| 64275-33-8 | 1,2-Heptadien-3-ylbenzene | C13H16 |
| 64275-73-6 | (5Z)-5-Octen-1-Ol | C8H16O |
| 64276-60-4 | 1-(4-Ethyl-1H-pyrrol-3-yl)ethanone | C8H11NO |
| 64276-62-6 | Ethyl 4-Phenylpyrrole-3-Carboxylate | C13H13NO2 |
| 64276-66-0 | 4-Methyl-1H-Pyrrole-3-Carboxylic acid | C6H7NO2 |
| 64277-22-1 | 1,1-Dimethoxy-N,N-dimethyl-1-butanamine | C8H19NO2 |
| 64277-87-8 | Methyl 3,5-bis(2-methyl-2-propanyl)benzoate | C16H24O2 |
| 64278-19-9 | 1,1-Dimethyl-5-indanamine | C11H15N |
| 64280-14-4 | delta-9-Tetrahydrocannabinol-11-oic acid | C21H28O4 |
| 64280-16-6 | Kaurane-3,16,17-Triol-3-O-beta-Glucopyranosyl-17-O-beta-Glucopyranoside | C32H54O13 |
| 64280-32-6 | 2,4-Bis(2-furylmethyl)furan | C14H12O3 |
| 64281-29-4 | 4-(2-Aminoethylamino)-Pyridine Hydrochloride | C7H12ClN3 |
| 64282-12-8 | 4-Fluoro-Phenylalanine Methyl Ester Hydrochloride (1:1) | |
| 64282-98-0 | Bis[2-[2-[4-[(2-cyanoethyl)[2-(2,5-dioxo-1-pyrrolidinyl)ethyl]amino]-2-methylphenyl]ethenyl]-1,3,3-trimethyl-3H-indolium]zinc(4+) sulfate (1:2) | C58H66N8O4Zn(SO4)2 |
| 64282-99-1 | 1'-Sulfoxysafrole | C10H10O6S |
| 64283-15-4 | 6-Amino-9-beta-D-Glucopyranosyl-1,9-Dihydro-2H-Purin-2-One | C11H15N5O6 |
| 64283-57-4 / 68134-15-6 | Sodium (Z)-2-Hydroxy-3-[(2-Hydroxyethyl)[2-[(1-Oxo-9-Octadecenyl)Amino]Ethyl]Amino]Propanesulphonate | C25H49N2NaO6S |
| 64283-59-6 | 2-Propenoic Acid, 2-Ethylhexyl Ester, Polymer With Diethenylbenzene And Ethenylmethylbenzene | C30H40O2 |